verbio Vereinigte BioEnergie (VBK) AI Stock Analysis

• Market Cap: €1.27B
• Dividend Yield: 1.01%
• Average Volume (3M): 165.84K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.42
• Revenue Growth: 8.65%
• EPS Growth: -379.83%
• Country: DE
• Employees: 1,521
• Sector: Energy
• Sector Strength: 52
• Industry: Chemicals - Specialty
• EPS (TTM): -0.06
• Shares Outstanding: 63,715,480
• 10 Day Avg. Volume: 196,028
• 30 Day Avg. Volume: 165,844
• PEG Ratio: <0.01
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.49
• P/FCF Ratio: -6.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €15.50
• Price Target Upside: -22.07% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 58 Neutral
• Price Target: €20.50 ▲(3.07% Upside)

The overall stock score reflects significant financial challenges, despite strong technical indicators. The earnings call provided some positive insights, but the company's valuation and financial performance remain concerning.

Positive Factors

Production Efficiency

High production efficiency in biodiesel indicates strong operational capabilities, enhancing the company's competitive position and profitability.

Revenue Growth

Significant growth in ethanol and biomethane production supports revenue expansion and strengthens market presence in renewable energy.

EBITDA Improvement

Improved EBITDA reflects enhanced financial performance, indicating better cost management and increased profitability potential.

Negative Factors

Rising Net Debt

Increased net debt may limit financial flexibility and strain cash flow, posing risks to long-term financial health and strategic initiatives.

Bioethanol Segment Loss

Continued losses in the Bioethanol segment highlight operational challenges, potentially affecting overall profitability and resource allocation.

Regulatory Uncertainty

Regulatory uncertainties, such as delays in RED III adoption, could impact future operations and strategic planning in the renewable energy sector.

verbio Vereinigte BioEnergie Business Overview & Revenue Model

Company Description

VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil corporations, oil traders, independent filling stations, haulage companies, public utilities, and vehicle fleets. VERBIO Vereinigte BioEnergie AG was founded in 2006 and is headquartered in Leipzig, Germany.

How the Company Makes Money

VBK generates revenue primarily through the sale of renewable energy products, including biodiesel and biomethane, which are sold to various industries and consumers. The company benefits from government subsidies and incentives aimed at promoting renewable energy use, which enhances its profitability. Additionally, VBK has established key partnerships with agricultural producers for the sourcing of raw materials, such as organic waste and crops, which further supports its production processes. The diversification of its biofuel offerings and investment in advanced technologies also contribute to its revenue streams, positioning VBK as a competitive player in the bioenergy market.

verbio Vereinigte BioEnergie Financial Statement Overview

Summary

The company faces significant financial challenges, with declining profitability and negative margins. The balance sheet shows moderate leverage but poor returns on equity, and cash flow analysis reveals liquidity concerns with negative free cash flow growth.

Income Statement

The income statement shows a concerning trend with declining profitability. The TTM data reveals a negative net profit margin of -8.74% and a negative EBIT margin of -7.41%, indicating operational challenges. Revenue growth is modest at 5.08%, but the company has struggled to maintain profitability, as seen in the negative EBITDA margin of 0.97%. Historically, the company had stronger margins, but recent performance has deteriorated significantly.

Balance Sheet

The balance sheet reflects moderate leverage with a debt-to-equity ratio of 0.36, which is manageable. However, the return on equity is negative at -16.23% in the TTM, highlighting inefficiencies in generating returns for shareholders. The equity ratio is stable, suggesting a reasonable level of financial stability, but the declining ROE is a concern.

Cash Flow

Cash flow analysis indicates significant challenges, with negative free cash flow growth and a free cash flow to net income ratio of -8.55 in the TTM. Operating cash flow is positive but insufficient to cover net income, as shown by the low operating cash flow coverage ratio of 0.045. The company's cash flow position has weakened, raising concerns about liquidity and financial flexibility.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.66B	1.58B	1.67B	1.97B	1.81B	1.03B
Gross Profit	107.69M	37.12M	292.45M	381.91M	626.92M	271.64M
EBITDA	37.49M	-54.41M	122.92M	242.68M	494.81M	166.48M
Net Income	-119.11M	-138.01M	19.96M	132.02M	315.63M	93.20M
Balance Sheet
Total Assets	1.28B	1.28B	1.38B	1.30B	1.13B	678.62M
Cash, Cash Equivalents and Short-Term Investments	72.35M	64.41M	126.70M	170.31M	300.50M	105.34M
Total Debt	296.94M	268.86M	194.20M	189.97M	49.39M	46.48M
Total Liabilities	540.23M	536.78M	449.54M	385.36M	310.16M	168.75M
Stockholders Equity	743.18M	746.29M	925.67M	909.47M	816.23M	507.85M
Cash Flow
Free Cash Flow	-117.03M	-117.96M	-54.38M	-177.12M	210.15M	49.90M
Operating Cash Flow	2.69M	13.88M	116.78M	26.09M	325.03M	117.18M
Investing Cash Flow	-108.25M	-120.06M	-144.90M	-266.43M	-113.62M	-46.56M
Financing Cash Flow	61.59M	49.88M	-19.53M	112.21M	-18.48M	-18.76M

verbio Vereinigte BioEnergie Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 19.89
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Positive. The current price of 19.89 is above the 20-day moving average (MA) of 18.24, above the 50-day MA of 16.65, and above the 200-day MA of 12.05, indicating a bullish trend. The MACD of 0.70 indicates Positive momentum. The RSI at 63.91 is Neutral, neither overbought nor oversold. The STOCH value of 63.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:VBK.

verbio Vereinigte BioEnergie Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACT	77 Outperform	€1.43B	24.54	29.12%	1.28%	1.03%	25.48%
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
WCH	62 Neutral	€3.37B	13.98	―	3.69%	-10.63%	-23.15%
VBK	58 Neutral	€1.27B	-10.64	-14.66%	1.01%	8.65%	-379.83%
EVK	54 Neutral	€6.13B	64.49	1.08%	8.90%	-5.92%	-58.33%
1COV	52 Neutral	€12.42B	-24.64	-7.19%	―	-5.27%	-75.47%
LXS	46 Neutral	€1.47B	-6.04	-5.69%	0.59%	-6.82%	71.94%

verbio Vereinigte BioEnergie Corporate Events

Verbio Earnings Call: Strategic Wins Amid Financial Struggles

The recent earnings call for Verbio Vereinigte BioEnergie presented a mixed sentiment, with strategic achievements and regulatory advancements being overshadowed by significant financial challenges. While the company expressed optimism about future regulatory support and strategic expansions, current financial struggles, particularly in Europe, remain a substantial concern.